Likely Diagnosis and Next Steps
This patient most likely has post-infectious cough (subacute cough) from a viral upper respiratory infection, with post-tussive vomiting as a complication of severe coughing paroxysms; however, pertussis must be ruled out given the 4-day duration, post-tussive vomiting, and peak cough timing. 1, 2
Immediate Diagnostic Priorities
Rule Out Pertussis First
- Any cough ≥2 weeks with paroxysmal episodes and post-tussive vomiting should be considered pertussis until proven otherwise, but this patient is only at day 4, making typical viral post-infectious cough more likely 1, 2
- However, the combination of paroxysmal coughing with post-tussive vomiting warrants obtaining a nasopharyngeal aspirate or Dacron swab for Bordetella pertussis culture to definitively exclude this diagnosis 1
- If pertussis is suspected based on clinical presentation or local outbreak, start azithromycin 500 mg daily for 3-5 days immediately without waiting for culture results, as early treatment within the first 2 weeks diminishes paroxysms and prevents transmission 1, 2
- PCR testing is available but not standardized for routine clinical use 1
Assess for Red Flag Features
- Check for tachypnea (≥24 breaths/min), tachycardia (≥100 bpm), or fever (≥38°C) which would suggest pneumonia requiring chest radiography 2, 3
- The normal vital signs and physical exam make serious pathology unlikely, but remain vigilant 2
- Hemoptysis, breathlessness, or focal lung findings require immediate chest imaging 4, 3
Most Likely Diagnosis: Viral Post-Infectious Cough
Given the 4-day duration, dry cough with sensation of phlegm, midday peak timing, and post-tussive vomiting after intense coughing, this represents acute viral upper respiratory infection with post-infectious airway inflammation 1, 4, 3
Pathophysiology
- Post-viral airway inflammation causes bronchial hyperresponsiveness, mucus hypersecretion, and impaired mucociliary clearance 1, 3
- The vomiting is a mechanical consequence of severe coughing paroxysms, not necessarily indicative of pertussis at this early stage 1
- Most acute viral coughs are self-limiting and resolve within 1-3 weeks 4, 3
Treatment Algorithm
First-Line Symptomatic Management (Current Stage: Day 4)
Reassure the patient that this is likely self-limiting viral cough expected to resolve within 1-3 weeks 4, 3
Simple home remedies are first-line: honey and lemon mixture is the simplest, cheapest, and often effective treatment 4
The dextromethorphan + guaifenesin (Robitussin DM) she is taking is appropriate, but the dose may be subtherapeutic 4, 2
Voluntary cough suppression through central modulation may reduce cough frequency 4
If Symptoms Persist or Worsen (Days 7-21)
At 2 weeks: If cough persists with paroxysmal features and post-tussive vomiting, strongly suspect pertussis and obtain nasopharyngeal culture while starting empiric macrolide therapy 1, 2
At 3 weeks: If still symptomatic, consider trial of inhaled ipratropium bromide as first-line pharmacologic therapy for post-infectious cough 1, 4
- Ipratropium has been shown to attenuate post-infectious cough 1
If ipratropium fails and cough adversely affects quality of life:
- Consider inhaled corticosteroids for persistent post-infectious airway inflammation 1
- For severe paroxysms, prednisone 30-40 mg daily for a short, finite period after ruling out other causes 1, 2
- Central antitussives (codeine or dextromethorphan 60 mg) only when other measures fail 1, 4
Critical Threshold: 8 Weeks
If cough persists beyond 8 weeks total duration, the diagnostic approach must fundamentally shift to systematically evaluate for 1, 3:
- Upper airway cough syndrome (chronic rhinosinusitis/postnasal drip)
- Asthma or cough-variant asthma
- Gastroesophageal reflux disease (GERD)
- Eosinophilic bronchitis
What NOT to Do
- Do not prescribe antibiotics for viral post-infectious cough unless bacterial sinusitis or pertussis is confirmed, as they provide no benefit and contribute to resistance 1, 3
- Avoid codeine or pholcodine as they have no greater efficacy than dextromethorphan but significantly worse side effect profiles 4
- Do not use subtherapeutic doses of dextromethorphan (<60 mg) and expect adequate cough suppression 4, 2
- Do not misclassify this as chronic cough at day 4, as management differs significantly 2, 3
Additional Considerations
Assess for Contributing Factors
- GERD can be triggered or worsened by vigorous coughing and may require empiric proton pump inhibitor trial if symptoms suggest reflux 1, 3
- Postnasal drip from concurrent upper airway inflammation may benefit from first-generation antihistamines, particularly for nocturnal cough 4
- Asthma or reactive airway disease should be considered if there is any wheezing, breathlessness, or response to bronchodilators 1, 3
Common Pitfalls to Avoid
- Delaying pertussis treatment while waiting for laboratory confirmation decreases effectiveness 2
- Failing to recognize that the vomiting is post-tussive (mechanical from coughing) rather than primary gastrointestinal pathology 1
- Not recognizing that dextromethorphan preparations often contain additional ingredients like acetaminophen, requiring caution with dosing 5
- Assuming all cough requires suppression—if productive cough develops, suppression may impair clearance 4